These bioactive components appear to be capable of inhibiting three essential metabolic enzymes associated with diabetes: porcine pancreatic α-amylase (PPA), dipeptidyl peptidase-IV (DPP-IV), and pancreatic lipase (PPL) (42). This evidence concerns the gene PNLIP and diabetes mellitus.